Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 4 boards, counting each seat separately. Longest: Kiniksa Pharmaceuticals International plc, 3 years.
10x Genomics Inc.
Director
Rhythm Pharmaceuticals Inc.
Director
Kardigan Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Kiniksa Pharmaceuticals International plc June 3, 202597.6%
-
10x Genomics Inc. June 11, 202491.4%
-
Kiniksa Pharmaceuticals International plc June 5, 202498.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 17, 2026 | Kardigan Inc. | Grant or award | +20,706 | — | — |
| Jun 4, 2026 | 10x Genomics Inc. | Grant or award | +8,829 | — | — |
| May 29, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,799 | — | — |
| Jul 30, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +45,748 | $10.36 | $473,949 |
| Jul 30, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +18,760 | $15.47 | $290,217 |
| Jul 30, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | −64,508 | $29.90 | $1,928,789 |
| Jun 5, 2025 | Kiniksa Pharmaceuticals International plc | Option exercise | +3,173 | — | — |
| Jun 3, 2025 | 10x Genomics Inc. | Grant or award | +15,357 | — | — |
| Jun 11, 2024 | 10x Genomics Inc. | Grant or award | +8,649 | — | — |
| Jun 6, 2024 | Kiniksa Pharmaceuticals International plc | Option exercise | +4,373 | — | — |
| Jun 29, 2023 | Kiniksa Pharmaceuticals International plc | Option exercise | +5,000 | — | — |
| Jun 14, 2023 | 10x Genomics Inc. | Grant or award | +1,865 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.